This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example,...

Investors are trying to generate excess returns through active investment strategies. Since the outbreak of the financial crisis, investors face a situation where increased risks are accompanied by falling key interest rates. An optimal portfolio in terms of risk and return becomes a perpetual...

Swen Nadkarni delivers a systematic review of the literature on factors of leadership, composed of management, ownership and generation, and their influence on innovation in family businesses. For this purpose, he conducts an exhaustive systematic review process to analyze 66 relevant...